Literature DB >> 10948747

Classification/diagnostic criteria for GCA/PMR.

G G Hunder1.   

Abstract

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two common rheumatic diseases occurring in middle-aged and older persons. Their cause is unknown and in neither is there a single specific diagnostic test. As a result a combination of findings is needed for their diagnosis. The American College of Rheumatology has established criteria for the classification of GCA using two methods. These criteria are best used in research studies involving patients with a diagnosis of vasculitis. One method is based on the so-called traditional format. In this method the patient with vasculitis is classified as GCA if he/she manifests any 3 among the list of 5 criteria selected. The second method, the tree format or recursive partitioning method, starts with the clinical finding that best separates patients with GCA from others with vasculitis and then uses other criteria successively to point to a final decision regarding the presence or absence of GCA. Diagnostic criteria for GCA have not been formulated. Diagnostic criteria have been established for PMR by analysis of a series of patients, but in practice most rheumatologists use criteria established informally by consensus.

Entities:  

Mesh:

Year:  2000        PMID: 10948747

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications.

Authors:  P Riordan-Eva; K Landau; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.

Authors:  J Meller; F Strutz; U Siefker; A Scheel; C O Sahlmann; K Lehmann; M Conrad; R Vosshenrich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-04       Impact factor: 9.236

3.  An immunohistochemical analysis of folate receptor beta expression and distribution in giant cell arteritis - a pilot study.

Authors:  Shirley Albano-Aluquin; Jozef Malysz; Vincent R Aluquin; Manohar Ratnam; Nancy Olsen
Journal:  Am J Clin Exp Immunol       Date:  2017-12-20

Review 4.  Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.

Authors:  Tarik Belhocine; Daniel Blockmans; Roland Hustinx; Johan Vandevivere; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-17       Impact factor: 9.236

Review 5.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

6.  Estimating the Cost of Illness of Giant Cell Arteritis in the United States.

Authors:  Joseph B Babigumira; Meng Li; Denise M Boudreau; Jennie H Best; Louis P Garrison
Journal:  Rheumatol Ther       Date:  2017-01-13

7.  Vascular Ultrasound for Giant Cell Arteritis: Establishing a Protocol Using Vascular Sonographers in a Fast-Track Clinic in the United States.

Authors:  Charles Oshinsky; Alison M Bays; Ingeborg Sacksen; Elizabeth Jernberg; R Eugene Zierler; Andreas P Diamantopoulos; Jean W Liew; Sarah H Chung; P Scott Pollock
Journal:  ACR Open Rheumatol       Date:  2021-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.